Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: J Immunother. 2013 Oct;36(8):10.1097/CJI.0b013e3182a80237. doi: 10.1097/CJI.0b013e3182a80237

Figure 5.

Figure 5

A. MDSCs increased from baseline (day 0) to next consecutive evaluation (day 45). MDSCs may have contributed to failure to achieve an IFN-γ response to vaccine antigen. Fraction CD33+ of Lin-DR- were analyzed by flow cytometry. Remaining patients were not evaluable due to poor cell viability, sample not collected, or death.

Bars: mean ± standard error. * p < 0.05, Wilcoxon signed rank test. n.s. = not significant. For pairing, Spearman r2 = 0.94.

B. Peripheral T-regulatory cells did not appreciably decrease from baseline (day 0) to next consecutive evaluation (day 45), despite single bolus of intravenous cyclophosphamide. n = 8. Fraction CD25+CD127- of CD4+ were analyzed by flow cytometry. Remaining patients were not evaluable due to poor cell viability, sample not collected, or death.

Bars: mean ± standard error. n.s. = not significant, Wilcoxon signed rank test. For pairing, Spearman r2 = 1.0.